Education
About Us
Working with TipRanks
Follow Us
ANGLE plc (GB:CLBX)
LSE:CLBX
CLBX Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
ANGLE plc News
CLBX FAQ
What was ANGLE plc’s price range in the past 12 months?
ANGLE plc lowest share price was 1.00p and its highest was 17.45p in the past 12 months.
What is ANGLE plc’s market cap?
ANGLE plc’s market cap is £11.93M.
When is ANGLE plc’s upcoming earnings report date?
ANGLE plc’s upcoming earnings report date is Apr 23, 2026 which is in 98 days.
How were ANGLE plc’s earnings last quarter?
ANGLE plc released its earnings results on Sep 09, 2025. The company reported -0.029p earnings per share for the quarter, missing the consensus estimate of N/A by -0.029p.
Is ANGLE plc overvalued?
According to Wall Street analysts ANGLE plc’s price is currently Undervalued.
Does ANGLE plc pay dividends?
ANGLE plc does not currently pay dividends.
What is ANGLE plc’s EPS estimate?
ANGLE plc’s EPS estimate is -0.02.
How many shares outstanding does ANGLE plc have?
ANGLE plc has 1,136,402,700 shares outstanding.
What happened to ANGLE plc’s price movement after its last earnings report?
ANGLE plc reported an EPS of -0.029p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of ANGLE plc?
Currently, no hedge funds are holding shares in GB:CLBX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ANGLE plc
ANGLE plc (CLBX) is a biotechnology company specializing in the development of innovative liquid biopsy technologies for early cancer detection and monitoring. The company's flagship product is the Parsortix system, which enables the isolation and harvesting of circulating tumor cells (CTCs) from blood samples. ANGLE operates in the healthcare sector, focusing on oncology diagnostics and research applications, aiming to improve patient outcomes through non-invasive testing methods.